Living with COVID in Hunter New England: Escalation, Medication and Technology

As we reach target COVID-19 vaccination rates the majority of COVID-19 positive people will be managed in the community and won’t require hospitalisation. This webinar will continue the discussion regarding management of COVID-19 positive patients in Hunter New England as we transition into the ‘living with COVID’ phase of the pandemic across the region.

This session will cover:

• Evidence, current guidelines and local access for: Sotrovimab; Ronapreve; Molnupiravir and the new Pfizer oral protease inhibitor

• Role of inhaled budesonide for symptomatic patients with risk factors for disease progression

• Thresholds for admission and escalation processes

• Demonstration of the new shared care portal for management of the COVID-19 positive patient

• Opportunity for Q & A